$ cat ./records/co-founds-cepi-at-davos-to-develop-vaccines-against-epidemic-thre-2017.txt
Co-founds CEPI at Davos to develop vaccines against epidemic threats in 100 days
[RECORD.TXT] · cat --full
Gates co-launched the Coalition for Epidemic Preparedness Innovations (CEPI) at the World Economic Forum in Davos with co-funding from the Gates Foundation, the Wellcome Trust, and the governments of Norway, Japan, and Germany. CEPI's mission is to compress the time to develop safe vaccines against new epidemic threats from 10 years to as little as 100 days. CEPI later played a central role coordinating COVID-19 vaccine development including the Oxford-AstraZeneca and Moderna vaccines.
Source: https://cepi.net/
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
TerraPower signed agreement with China National Nuclear Corporation to develop Traveling Wave Reactor
Next →
Personally committed $100 million to Alzheimer's disease research
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.